• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

戊型肝炎病毒与实体器官移植受者的肾脏

Hepatitis E virus and the kidney in solid-organ transplant patients.

机构信息

Department of Nephrology, Dialysis and Organ Transplantation, CHU Rangueil, Toulouse, France.

出版信息

Transplantation. 2012 Mar 27;93(6):617-23. doi: 10.1097/TP.0b013e318245f14c.

DOI:10.1097/TP.0b013e318245f14c
PMID:22298032
Abstract

BACKGROUND

Hepatitis E virus (HEV) infection is an emerging disease in industrialized countries. Few data regarding genotype 3 HEV extrahepatic manifestations exist.

METHODS

We assessed kidney function and histology in solid-organ transplant patients during HEV infection. In all, 51 cases of genotype 3 HEV infections were diagnosed (34 kidney, 14 liver, and 3 kidney-pancreas transplant patients). Of these, 43.2% were cleared of the virus spontaneously within 6 months of infection, whereas 56.8% evolved to chronic hepatitis. Twelve of these patients completed a 3-month antiviral therapy and were followed up for 6 months posttreatment. Kidney function (estimated glomerular filtration rate [eGFR] obtained by the Modification of Diet in Renal Disease equation) and proteinuria were assessed before infection, during HEV infection and during follow-up. Kidney biopsies were obtained from patients with high proteinuria and decreased eGFR levels.

RESULTS

During HEV infection, there was a significant decrease in eGFR in both kidney- and liver-transplant patients. Glomerular diseases were observed in kidney biopsies obtained during the acute and chronic phases. This included membranoproliferative glomerulonephritis and relapses in IgA nephropathy. The majority of patients had cryoglobulinemia that became negative after HEV clearance. Kidney function improved and proteinuria decreased after HEV clearance.

CONCLUSION

HEV-associated glomerulonephritis seems to be an HEV-related extrahepatic manifestation. Further studies are required to confirm these observations.

摘要

背景

戊型肝炎病毒 (HEV) 感染是工业化国家的一种新兴疾病。关于基因型 3 HEV 肝外表现的数据很少。

方法

我们在 HEV 感染期间评估了实体器官移植患者的肾功能和组织学。共诊断出 51 例基因型 3 HEV 感染病例(34 例肾移植、14 例肝移植和 3 例肝肾联合移植患者)。其中,43.2%的患者在感染后 6 个月内自发清除病毒,而 56.8%的患者发展为慢性肝炎。其中 12 例患者完成了 3 个月的抗病毒治疗,并在治疗后随访 6 个月。在感染前、HEV 感染期间和随访期间评估肾功能(通过肾脏病饮食改良公式计算的估计肾小球滤过率[eGFR])和蛋白尿。对于蛋白尿和 eGFR 水平降低的患者进行肾活检。

结果

在 HEV 感染期间,肾移植和肝移植患者的 eGFR 均显著下降。在急性和慢性期的肾活检中观察到肾小球疾病。包括膜增殖性肾小球肾炎和 IgA 肾病的复发。大多数患者存在冷球蛋白血症,在 HEV 清除后转为阴性。HEV 清除后,肾功能改善,蛋白尿减少。

结论

HEV 相关性肾小球肾炎似乎是一种与 HEV 相关的肝外表现。需要进一步研究来证实这些观察结果。

相似文献

1
Hepatitis E virus and the kidney in solid-organ transplant patients.戊型肝炎病毒与实体器官移植受者的肾脏
Transplantation. 2012 Mar 27;93(6):617-23. doi: 10.1097/TP.0b013e318245f14c.
2
Influence of immunosuppressive therapy on the natural history of genotype 3 hepatitis-E virus infection after organ transplantation.免疫抑制治疗对器官移植后基因型 3 型肝炎病毒感染自然史的影响。
Transplantation. 2010 Feb 15;89(3):353-60. doi: 10.1097/TP.0b013e3181c4096c.
3
Infection with hepatitis E virus in kidney transplant recipients in southeastern France.法国东南部肾移植受者感染戊型肝炎病毒。
J Med Virol. 2013 Mar;85(3):462-71. doi: 10.1002/jmv.23469. Epub 2012 Dec 12.
4
Prevalence of hepatitis E virus infection in pediatric solid organ transplant recipients--a single-center experience.儿童实体器官移植受者中戊型肝炎病毒感染的患病率——单中心经验
Pediatr Transplant. 2012 Nov;16(7):742-7. doi: 10.1111/j.1399-3046.2012.01740.x. Epub 2012 Jun 28.
5
Successful treatment of hepatitis E virus-associated cryoglobulinemic membranoproliferative glomerulonephritis with ribavirin.利巴韦林成功治疗戊型肝炎病毒相关冷球蛋白血症性膜增生性肾小球肾炎
Transpl Infect Dis. 2015 Apr;17(2):279-83. doi: 10.1111/tid.12353. Epub 2015 Feb 24.
6
Ribavirin for chronic hepatitis E virus infection in transplant recipients.利巴韦林治疗肝移植受者慢性戊型肝炎病毒感染。
N Engl J Med. 2014 Mar 20;370(12):1111-20. doi: 10.1056/NEJMoa1215246.
7
Prevalence of hepatitis E virus infection in liver transplant recipients.肝移植受者中戊型肝炎病毒感染的患病率。
Liver Transpl. 2009 Oct;15(10):1225-8. doi: 10.1002/lt.21819.
8
Hepatitis E virus infection as a cause of graft hepatitis in liver transplant recipients.戊型肝炎病毒感染导致肝移植受者移植肝肝炎。
Liver Transpl. 2010 Jan;16(1):74-82. doi: 10.1002/lt.21958.
9
Characteristics of autochthonous hepatitis E virus infection in solid-organ transplant recipients in France.法国实体器官移植受者中本土型戊型肝炎病毒感染的特征。
J Infect Dis. 2010 Sep 15;202(6):835-44. doi: 10.1086/655899.
10
Chronic hepatitis E virus infection in liver transplant recipients.肝移植受者中的戊型肝炎病毒慢性感染
Liver Transpl. 2008 Apr;14(4):547-53. doi: 10.1002/lt.21480.

引用本文的文献

1
Extrahepatic Replication and Genomic Signatures of the Hepatitis E Virus in the Kidney.戊型肝炎病毒在肾脏中的肝外复制及基因组特征
Liver Int. 2025 Jul;45(7):e70183. doi: 10.1111/liv.70183.
2
Hepatitis E virus infection and renal injury in non-immunocompromised host: clinical investigation and rabbit model study.非免疫功能低下宿主中的戊型肝炎病毒感染与肾损伤:临床研究及兔模型研究
Front Cell Infect Microbiol. 2025 May 6;15:1583006. doi: 10.3389/fcimb.2025.1583006. eCollection 2025.
3
Antiviral resistance and barrier integrity at the maternal-fetal interface restrict hepatitis E virus from crossing the placental barrier.
母婴界面的抗病毒耐药性和屏障完整性限制戊型肝炎病毒穿过胎盘屏障。
Proc Natl Acad Sci U S A. 2025 May 6;122(18):e2501128122. doi: 10.1073/pnas.2501128122. Epub 2025 May 1.
4
Viral hepatitis E: Clinical manifestations, treatment, and prevention.戊型病毒性肝炎:临床表现、治疗与预防
Liver Res. 2024 Jan 6;8(1):11-21. doi: 10.1016/j.livres.2024.01.001. eCollection 2024 Mar.
5
Effect of Hepatitis E Virus on the Male Reproductive System: A Review of Current Evidence.戊型肝炎病毒对男性生殖系统的影响:现有证据综述
Viruses. 2025 Jan 5;17(1):66. doi: 10.3390/v17010066.
6
HEV ORF2 protein-antibody complex deposits are associated with glomerulonephritis in hepatitis E with reduced immune status.戊型肝炎病毒 ORF2 蛋白-抗体复合物沉积与免疫功能低下的戊型肝炎相关肾小球肾炎有关。
Nat Commun. 2024 Oct 14;15(1):8849. doi: 10.1038/s41467-024-53072-0.
7
Realm of hepatitis E: Challenges and opportunities.戊型肝炎领域:挑战与机遇
World J Exp Med. 2024 Jun 20;14(2):90481. doi: 10.5493/wjem.v14.i2.90481.
8
The Re-Emergence of Hepatitis E Virus in Europe and Vaccine Development.戊型肝炎病毒在欧洲的再现与疫苗研发。
Viruses. 2023 Jul 16;15(7):1558. doi: 10.3390/v15071558.
9
Hepatitis E Virus Infections: Epidemiology, Genetic Diversity, and Clinical Considerations.戊型肝炎病毒感染:流行病学、遗传多样性和临床注意事项。
Viruses. 2023 Jun 17;15(6):1389. doi: 10.3390/v15061389.
10
Evidence of a Link between Hepatitis E Virus Exposure and Glomerulonephritis Development.戊型肝炎病毒暴露与肾小球肾炎发展之间关联的证据。
Viruses. 2023 Jun 15;15(6):1379. doi: 10.3390/v15061379.